Elevance Health Reports Results for Fourth Quarter and Full

4Q 2023 operating revenue of $42.5 billion, up 7.0% from 4Q 2022; FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022



4Q 2023 GAAP diluted EPS1 of $3.63, up 1.1% from 4Q 2022 and...

Related Keywords

Gailk Boudreaux , , Carelon Services , Elevance Health On Linkedin , Carelon Services Consumers , Health Products Services , Employer Group , Elevance Health , Employer Group Fee , International Replay , Carelon Global Solutions , Elevance Health Inc , Administration Members , Service Fees , Employer Group Risk , Chief Executive Officer , Health Benefits , Claims Payable , Federal Health Products , Carelon Global , Reportable Segment Highlight Details , Commercial Health Benefits , Affordable Care Act , Operating Gain , Standard Time , Domestic Replay , Release Financial Schedules , Year Ended December , Full Year Consolidated Statements , Consolidated Statement , Financial Information , Medical Claims , Disability Members , Months Ended December , Operating Revenue , Ended December , Shareholder Net Income , Shareholder Net Income Per Share , Operating Expense , Total Revenue , Consolidated Statements , Accounting Standards Update , End Medical Enrollment , Pre Tax Items , Intangible Assets , Markets ,